Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines
US6043231A · kind A · utility
43Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 1993 |
| Grant date | Mar 28, 2000 |
| Priority date | — |
| Expiry date | Aug 31, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating mammals suffering from conditions associated with excess phospholipase A.sub.2 activity and/or production comprising administering to the mammal an effective amount of a non-antimicrobial tetracycline sufficient to inhibit excess phospholipase A.sub.2 activity and/or production is disclosed. A pharmaceutical composition is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.